FindTrial
Sign In

Application of multimodal ultrasound imaging in neoadjuvant chemotherapy in patients with breast cancer

Application of multimodal ultrasound imaging in neoadjuvant chemotherapy in patients with breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048065
Enrollment
Unknown
Registered
2021-06-29
Start date
2021-08-01
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Case series:Nil

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Informed and voluntarily joined the study; 2. Commitment to follow the research procedures and cooperate with the whole process study; 3. Pathologically confirmed as patients with breast cancer; 4. It met the requirements of neoadjuvant chemotherapy, and improved routine ultrasound, ultrasound stomography and obtained postoperative pathology.

Exclusion criteria

Exclusion criteria: 1. Known contrast agent allergy person; 2. Pre-NAC or/and preoperative ultrasound imaging data were missing; 3. Surgical pathology data after NAC was not operative or missing; 4. The researchers considered not suitable for patients enrolled in this study.

Design outcomes

Primary

MeasureTime frame
Ultrasound parameter;—

Countries

China

Contacts

Public ContactXie Mingxing

Department of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

xiemx64@126.com+86 13607108938

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026